News | Neuro Imaging | September 29, 2015

Nico Collaborating with Hitachi Aloka Medical on New Ultrasound Brain Probe

Device coordinates with Nico’s BrainPath to offer improved visualization of difficult-to-reach brain tumors

Nico Corp., Hitachi Aloka Medical, BrainPath, ultrasound probe, brain tumors

Image courtesy of Nico Corp.

September 29, 2015 — Neurosurgical device manufacturer Nico Corp. and surgical ultrasound provider Hitachi Aloka Medical America Inc. have collaborated to provide neurosurgeons real-time, intraoperative imaging to assist with greater extent of resection when accessing brain tumors using the Nico BrainPath.

"The new Hitachi Aloka ultrasound probe provides real-time intraoperative imaging feedback with the economics and efficiency of an ultrasound," said Juan Alzate, M.D., neurosurgeon with The American Center for Spine and Neurosurgery and Cancer Treatment Centers of America in Chicago. "With the immediate feedback it provides surgeons within a minimally invasive corridor, they can confirm location of the brain tumor, proximity of nearby vessels that may be encountered beyond the direct field of view and the extent of the resection."

In the United States alone, nearly 500,000 patients are diagnosed each year with brain abnormalities such as tumors and hemorrhagic stroke. Due to the location of the abnormality and the complex nature of the brain, more than 50 percent of those patients have few, if any, effective surgical treatment options. While surgical resection followed by adjuvant therapy is considered the gold standard for neurosurgical treatment of brain tumors, the risks of debilitating deficits has been too great until now to attempt many of these surgeries.

A unique surgical approach to these subcortical abnormalities using the BrainPath has been used in more than 2,500 procedures at more than 60 institutions throughout the United States. In some cases, visualization of the tumor can be difficult without creating a larger access point, increasing the chances of deficits. The new Hitachi Aloka ultrasound probe, still under development, is specifically designed for use with the BrainPath. It uses ultrasound technology to assist surgeons in precisely and efficiently locating tumors beyond their direct vision in the surgical field.

This collaboration comes just one month after Nico announced that, based on the evaluation of the clinical effectiveness and documented patient outcomes when using BrainPath, the U.S. Food and Drug Administration (FDA) granted the BrainPath clearance for specific indications for subcortical access to brain tumors, cysts and vascular disease.

For more information: www.niconeuro.com, www.hitachi-aloka.com

Related Content

Fujifilm SonoSite Unveils Full Suite of iViz Point-of-Care Transducers

The L25v ultrasound transducer for the Fujifilm Sonosite iViz is available for superficial applications such as ophthalmic, arterial, venous, lung and nerve. Image courtesy of Fujifilm Sonosite.

Technology | Ultrasound Imaging | August 15, 2018
Fujifilm SonoSite Inc. announced the launch of two new transducers for the SonoSite iViz point-of-care ultrasound, now...
Exact Imaging Becomes UroGPO Imaging Partner
News | Ultrasound Imaging | August 10, 2018
Exact Imaging announced that it has become a UroGPO Imaging Partner, joining the North American urology-specific group...
Aidoc Receives FDA Clearance for AI Detection of Acute Intracranial Hemorrhage
Technology | Clinical Decision Support | August 08, 2018
Aidoc announced that it was granted U.S. Food and Drug Administration (FDA) clearance for the first product of its...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Konica Minolta Healthcare Announces UGPro Solution for Ultrasound-Guided Procedures
News | Ultrasound Imaging | August 07, 2018
Konica Minolta Healthcare Americas Inc. announces UGPro Solution, a new initiative that provides complete solutions for...
CT Decision Instrument Reliably Guides Pediatric Blunt Trauma imaging Decisions

This is a four-site prospective observational cohort. Image courtesy of Kirsty Challen, B.Sc., MBCHB, MRES, Ph.D., Lancashire Teaching Hospitals, United Kingdom.

News | Clinical Decision Support | July 18, 2018
A new study finds The Pediatric NEXUS Head Computed Tomography (CT) Decision Instrument (DI) reliably identifies blunt...
Artificial Intelligence Provides Faster, Clearer MRI Scans

A new artificial-intelligence-based approach to image reconstruction, called AUTOMAP, yields higher quality images from less data, reducing radiation doses for CT and PET and shortening scan times for MRI. Shown here are MR images reconstructed from the same data with conventional approaches, at left, and AUTOMAP, at right. Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital

News | Artificial Intelligence | July 17, 2018
A research team with funding from the National Institute for Biomedical Imaging and Bioengineering (NIBIB) has...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
iSchemaView Brings RAPID Imaging Platform to Australia and New Zealand
News | Stroke | July 13, 2018
iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID cerebrovascular...
Siemens Healthineers Launches Acuson Sequoia Ultrasound
Technology | Ultrasound Imaging | July 12, 2018
July 12, 2018 — Siemens Healthineers recently announced the launch of its new ultrasound system, the Acuson Sequoia.
Overlay Init